| abstract |
The present invention relates to a deuterated diaminopyrimidine compound and a drug composition comprising the compound thereof. In particular, the present invention relates to a pharmaceutical composition comprising a deuterated diaminopyrimidine compound represented by formula (I) and a compound thereof, or a crystalline form, a pharmaceutically acceptable salt, hydrate or solvate thereof. The compounds of the present invention can be used for the treatment and / or prophylaxis of protein kinase related diseases such as cell proliferative diseases, cancer, immune diseases and the like. |